SHW Stock Analysis: Sherwin-Williams | NYSE
Specialty Chemicals | NYSE, USA | Market Cap: 77.501m USD | 12M Return: -3.5% | US8243481061 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 518M
EPS Trend: 93.3%
Qual. Beats: 0
Rev. Trend: 85.1%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Sherwin-Williams Company (NYSE: SHW) is a leading global manufacturer and distributor of paints, coatings, and related products, serving professional, industrial, commercial, and retail customers. Founded in 1866 and headquartered in Cleveland, Ohio, the company operates through three core segments: Paint Stores Group (company-owned Sherwin-Williams branded stores targeting contractors and DIY consumers), Consumer Brands Group (branded and private-label products sold through home centers, hardware stores, and distributors), and Performance Coatings Group (industrial, automotive refinish, protective and marine, coil, and packaging coatings). SHW has a global footprint spanning North America, South America, the Caribbean, Europe, Asia, and Australia.
As a large-cap stock in the Materials sector under the GICS Specialty Chemicals sub-industry, Sherwin-Williams benefits from a vertically integrated business model that combines direct-to-consumer retail through its store network with B2B distribution channels. The specialty chemicals and coatings industry is characterized by high barriers to entry driven by brand equity, proprietary formulations, and scale efficiencies, which have historically supported stable margins for established players like SHW.
- Paint Stores Group drives revenue on pricing power
- Housing starts decline pressures architectural coatings demand
- Titanium dioxide costs continue to compress gross margins
| Net Income: 2.68b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 2.16 > 1.0 |
| NWC/Revenue: -11.33% < 20% (prev -5.70%; Δ -5.62% < -1%) |
| CFO/TA 0.14 > 3% & CFO 3.68b > Net Income 2.68b |
| Net Debt (15.9b) to EBITDA (4.70b): 3.37 < 3 |
| Current Ratio: 0.71 > 1.5 & < 3 |
| Outstanding Shares: last quarter (242.8m) vs 12m ago -2.49% < -2% |
| Gross Margin: 48.69% > 18% (prev 48.88%; Δ -0.19% > 0.5%) |
| Asset Turnover: 93.71% > 50% (prev 88.82%; Δ 4.89% > 0%) |
| Interest Coverage Ratio: 7.47 > 6 (EBIT TTM 4.02b / Interest Expense TTM 538.4m) |
| A: -0.10 (Total Current Assets 7.03b - Total Current Liabilities 9.85b) / Total Assets 27.0b |
| B: 0.10 (Retained Earnings 2.64b / Total Assets 27.0b) |
| C: 0.15 (EBIT TTM 4.02b / Avg Total Assets 26.6b) |
| D: 0.17 (Book Value of Equity 3.98b / Total Liabilities 23.0b) |
| Altman-Z'' = 0.83 = B |
| DSRI: 1.08 (Receivables 3.60b/3.12b, Revenue 24.9b/23.3b) |
| GMI: 1.00 (GM 48.88% / 48.69%) |
| AQI: 0.93 (AQ_t 0.50 / AQ_t-1 0.54) |
| SGI: 1.07 (Revenue 24.9b / 23.3b) |
| TATA: -0.04 (NI 2.68b - CFO 3.68b) / TA 27.0b) |
| Beneish M = -2.95 (Cap -4..+1) = A |
As of October 31, 2026, the stock is trading at USD 332.61 with a total of 2,210,532 shares traded. Over the past week, the price has changed by -1.32%, over one month by +0.66%, over three months by -3.32% and over the past year by -3.49%.
Current recommended Stop Loss: 320.50 (which is 3.6% or 1.3 ATR below the current price).
Sherwin-Williams has received a consensus analysts rating of 3.93. Therefore, it is recommended to buy SHW.
- StrongBuy: 12
- Buy: 3
- Hold: 14
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 378.3 | 13.7% |
P/E Trailing = 29.5124
P/E Forward = 23.753
P/S = 3.111
P/B = 19.8054
P/EG = 2.0997
Revenue TTM = 24.9b USD
EBIT TTM = 4.02b USD
EBITDA TTM = 4.70b USD
Long Term Debt = 9.32b USD (from longTermDebt, last fiscal year)
Short Term Debt = 4.34b USD (from shortTermDebt, last quarter)
Debt = 16.1b USD (from shortLongTermDebtTotal, last quarter) + Leases 2.14b
Net Debt = 15.9b USD (calculated: Debt 16.1b - CCE 264.2m)
Enterprise Value = 93.4b USD (77.5b + Debt 16.1b - CCE 264.2m)
Interest Coverage Ratio = 7.47 (Ebit TTM 4.02b / Interest Expense TTM 538.4m)
EV/FCF = 30.33x (Enterprise Value 93.4b / FCF TTM 3.08b)
FCF Yield = 3.30% (FCF TTM 3.08b / Enterprise Value 93.4b)
FCF Margin = 12.35% (FCF TTM 3.08b / Revenue TTM 24.9b)
Net Margin = 10.74% (Net Income TTM 2.68b / Revenue TTM 24.9b)
Gross Margin = 48.69% ((Revenue TTM 24.9b - Cost of Revenue TTM 12.8b) / Revenue TTM)
Gross Margin QoQ = 47.77% (prev 49.17%)
Tobins Q-Ratio = 3.46 (Enterprise Value 93.4b / Total Assets 27.0b)
Interest Expense / Debt = 3.34% (Interest Expense 538.4m / Debt 16.1b)
Taxrate = 23.43% (818.7m / 3.49b)
NOPAT = 3.08b (EBIT 4.02b * (1 - 23.43%))
Current Ratio = 0.71 (Total Current Assets 7.03b / Total Current Liabilities 9.85b)
Debt / Equity = 4.05 (Debt 16.1b / totalStockholderEquity, last quarter 3.98b)
Debt / EBITDA = 3.37 (Net Debt 15.9b / EBITDA 4.70b)
Debt / FCF = 5.15 (Net Debt 15.9b / FCF TTM 3.08b)
Total Stockholder Equity = 4.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.07% (Net Income 2.68b / Total Assets 27.0b)
RoE = 63.49% (Net Income TTM 2.68b / Total Stockholder Equity 4.22b)
RoCE = 29.72% (EBIT 4.02b / Capital Employed (Equity 4.22b + L.T.Debt 9.32b))
RoIC = 14.54% (NOPAT 3.08b / Invested Capital 21.2b)
WACC = 6.57% (E(77.5b)/V(93.6b) * Re(7.41%) + D(16.1b)/V(93.6b) * Rd(3.34%) * (1-Tc(0.23)))
Discount Rate = 7.41% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.52 | Cagr: -2.02%
[DCF] Terminal Value 77.97% ; FCFF base≈2.82b ; Y1≈3.23b ; Y5≈4.75b
[DCF] Fair Price = 230.4 (EV 71.5b - Net Debt 15.9b = Equity 55.7b / Shares 241.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 93.25 | EPS CAGR: 4.65% | SUE: -0.10 | # QB: 0
Revenue Correlation: 85.05 | Revenue CAGR: 2.57% | SUE: 0.82 | # QB: 0
EPS current Quarter (2027-03-31): EPS=2.52 | Chg30d=-2.53% | Revisions=+10% | Analysts=11
EPS current Year (2026-12-31): EPS=12.04 | Chg30d=-0.48% | Revisions=-57% | GrowthEPS=+5.3% | GrowthRev=+6.8%
EPS next Year (2027-12-31): EPS=13.32 | Chg30d=-2.01% | Revisions=-62% | GrowthEPS=+10.6% | GrowthRev=+4.2%
[Analyst] Revisions Ratio: -42% (up=4, down=12)